Trial intelligence / Profile preview

Active safety monitoring of Maren Runchang softgel after marketing re-evaluation

ChiCTR2300074805Phase 4Recruiting

Sponsor
The Third Medical Center of the Chinese People's Liberation Army General Hospital
Start
Jul 2023
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Ma Ren Run Chang Wan in constipation, sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoints: Adverse events, Vital signs and 1 more. Started Jul 2023; status: recruiting.

02

Drugs

Ma Ren Run Chang Wan
03

Conditions

constipation

Beyond the preview

Go deeper on ChiCTR2300074805.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300074805.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call